![Infinity Kappa 1000W Kappa Series 10 Infinity Kappa 1000W Kappa Series 10](https://images.crutchfieldonline.com/ImageHandler/trim/750/457/products/2019/8/108/g108KAPPA1M-F.jpg)
Infinity Kappa 1000W Kappa Series 10" subwoofer with selectable 2- or 4-ohm impedance at Crutchfield
![Zeta Phi Beta Week flyer (Rho Sigma, University of Missouri - Kansas City) | Zeta phi beta, University of missouri, Zeta Zeta Phi Beta Week flyer (Rho Sigma, University of Missouri - Kansas City) | Zeta phi beta, University of missouri, Zeta](https://i.pinimg.com/736x/20/16/e7/2016e746d16b092493c1e89db1613a76--event-flyers-zeta-phi-beta.jpg)
Zeta Phi Beta Week flyer (Rho Sigma, University of Missouri - Kansas City) | Zeta phi beta, University of missouri, Zeta
![Life | Free Full-Text | Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities | HTML Life | Free Full-Text | Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities | HTML](https://www.mdpi.com/life/life-11-01217/article_deploy/html/images/life-11-01217-g009.png)
Life | Free Full-Text | Co-Evolution of Opioid and Adrenergic Ligands and Receptors: Shared, Complementary Modules Explain Evolution of Functional Interactions and Suggest Novel Engineering Possibilities | HTML
![Intelligent system for drowsiness recognition based on ear canal electroencephalography with photoplethysmography and electrocardiography - ScienceDirect Intelligent system for drowsiness recognition based on ear canal electroencephalography with photoplethysmography and electrocardiography - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0020025518302561-gr4.jpg)
Intelligent system for drowsiness recognition based on ear canal electroencephalography with photoplethysmography and electrocardiography - ScienceDirect
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig1_HTML.jpg)